
The episode discusses the implications of the FDA's decision to reclassify certain peptides and its impact on healthcare access and costs.
Get Retatrutide & All Peptides -->DianeKazer.com/PEPTIDES Shop via Limitless VIP Button on this page for Retatrutide Join our NEW Elite VIP Tribe Starting April 7! $100 off Each Month Only Through April 1! --> DianeKazer.com/VIP Apply to Become a Patient -->DianeKazer.com/PATIENT There's a massive shift happening in healthcare right now…and if you care about freedom, access and the future of peptides, you need to innerstand what this means. HHS Secretary Robert F. Kennedy Jr. has just announced that the FDA plans to move 19 peptides from Category 2 to Category 1. What does that mean? These peptides would become FDA-recognized and legally prescribable medications. At first glance, that sounds like a celebration. But there's another side of this story. Because when peptides move into the pharmaceutical system… ⚠️ Prices often increase dramatically ⚠️ Access becomes more controlled ⚠️ Many peptides may only be available through doctors and pharmacies Peptides many people currently access at a fraction of the price could soon cost 10x or more. And this signals something bigger. We are witnessing a major turning point in healthcare. And we're already starting to see the ripple…
Host: Diane Kazer
Organizations: FDA, HHS
Products: Retatrutide
Explore listener stats, chart rankings, contacts and more on the Cleanse Heal Ignite podcast page.